XML 26 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

The following tables summarize the fair value of the Company’s financial instruments (in thousands):

 

 

 

 

 

 

 

Fair Value Measurements Using

 

 

 

March 31,

2021

 

 

Quoted Prices

in Active

Markets for

Identical Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

61,564

 

 

$

61,564

 

 

$

 

 

$

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

55,299

 

 

$

 

 

$

55,299

 

 

 

 

Commercial paper

 

 

60,462

 

 

 

 

 

 

60,462

 

 

 

 

U.S. Government securities

 

 

120,894

 

 

 

 

 

 

120,894

 

 

 

 

Total short-term investments

 

 

236,655

 

 

 

 

 

 

236,655

 

 

 

 

Total

 

$

298,219

 

 

$

61,564

 

 

$

236,655

 

 

$

 

 

 

 

 

 

 

 

Fair Value Measurements Using

 

 

 

December 31,

2020

 

 

Quoted Prices

in Active

Markets for

Identical Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

94,631

 

 

$

94,631

 

 

$

 

 

$

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

48,614

 

 

$

 

 

$

48,614

 

 

 

 

Commercial paper

 

 

63,445

 

 

 

 

 

 

63,445

 

 

 

 

U.S. Government securities

 

 

106,162

 

 

 

 

 

 

106,162

 

 

 

 

Total short-term investments

 

 

218,221

 

 

 

 

 

 

218,221

 

 

 

 

Total

 

$

312,852

 

 

$

94,631

 

 

$

218,221

 

 

$

 

Cash Equivalents and Short-Term Investments

Financial assets measured at fair value on a recurring basis consist of the Company’s cash equivalents and short-term investments. Cash equivalents consisted of money market funds and short-term investments consisted of commercial paper, U.S. Government securities and corporate bonds. The Company obtains pricing information from its investment manager and generally determines the fair value of investment securities using standard observable inputs, including reported trades, broker/dealer quotes, and bids and/or offers.

Investments are classified as Level 1 within the fair value hierarchy if their quoted prices are available in active markets for identical securities. Investments in money market funds of $61.6 million and $94.6 million as of March 31, 2021 and December 31, 2020, respectively, were classified as Level 1 instruments and were included in cash and cash equivalents.

Investments in marketable securities are valued using Level 2 inputs. Level 2 securities are initially valued at the transaction price and subsequently valued and reported upon utilizing inputs other than quoted prices that are observable either directly or indirectly, such as quotes from third-party pricing vendors. Fair values determined by Level 2 inputs, which utilize data points that are observable such as quoted prices, interest rates and yield curves, require the exercise of judgment and use of estimates, that if changed, could significantly affect the Company’s financial position and results of operations. The marketable securities of $236.7 million and $218.2 million as of March 31, 2021 and December 31, 2020, respectively, were classified as Level 2 instruments and were included in short-term investments. Accrued interest receivable related to short-term investments were $0.8 million and $1.1 million as of March 31, 2021 and December 31, 2020, respectively, and included as part of prepaid expenses and other current assets in the balance sheets.

The following tables summarize the Company’s short-term investments accounted for as available-for-sale securities as of March 31, 2021 and December 31, 2020 (in thousands):

 

 

 

 

 

March 31, 2021

 

 

 

Maturity

(in years)

 

Amortized

Cost

 

 

Unrealized

Losses

 

 

Unrealized

Gains

 

 

Estimated

Fair Value

 

Corporate debt securities

 

1 year or less

 

$

55,308

 

 

$

(12

)

 

$

3

 

 

$

55,299

 

Commercial paper

 

1 year or less

 

 

60,462

 

 

 

 

 

 

 

 

 

60,462

 

U.S. Government securities

 

1 year or less

 

 

120,851

 

 

 

 

 

 

 

43

 

 

 

120,894

 

Total

 

 

 

$

236,621

 

 

$

(12

)

 

$

46

 

 

$

236,655

 

 

 

 

 

 

December 31, 2020

 

 

 

Maturity

(in years)

 

Amortized

Cost

 

 

Unrealized

Losses

 

 

Unrealized

Gains

 

 

Estimated

Fair Value

 

Corporate debt securities

 

1 year or less

 

$

48,616

 

 

$

(6

)

 

$

4

 

 

$

48,614

 

Commercial paper

 

1 year or less

 

 

63,445

 

 

 

 

 

 

 

 

 

63,445

 

U.S. Government securities

 

1 year or less

 

 

106,157

 

 

 

(7

)

 

 

12

 

 

$

106,162

 

Total

 

 

 

$

218,218

 

 

$

(13

)

 

$

16

 

 

$

218,221

 

 

The Company has classified all of its available-for-sale investment securities as current assets on the balance sheet based on the highly liquid nature of these investment securities and because these investment securities are considered available for use in current operations.

The Company considers whether unrealized losses have resulted from a credit loss or other factors. The unrealized losses on the Company’s available-for-sale securities as of March 31, 2021 and December 31, 2020 were caused by fluctuations in market value and interest rates as a result of the economic environment. The Company concluded that an allowance for credit losses was unnecessary as of March 31, 2021 and that there were no impairments as of December 31, 2020. It is neither management’s intention to sell nor is it more likely than not that the Company will be required to sell these investments prior to recovery of their cost basis or recovery of fair value. Unrealized gains and losses are included in accumulated other comprehensive income.

There was no realized gain or loss on available-for-sale securities in the periods presented. The Company uses the specific identification method to determine the cost basis of investments sold.